SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-20-000131
Filing Date
2020-07-31
Accepted
2020-07-31 12:02:43
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20200630.htm   iXBRL 10-Q 3568917
2 EX-31.1 lly-6302020x10qxexhibi.htm EX-31.1 13377
3 EX-31.2 lly-6302020x10qxexhibi1.htm EX-31.2 13399
4 EX-32 lly-6302020x10qxexhibi2.htm EX-32 11306
  Complete submission text file 0000059478-20-000131.txt   14069009

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20200630.xsd EX-101.SCH 50141
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20200630_cal.xml EX-101.CAL 89594
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20200630_def.xml EX-101.DEF 286372
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20200630_lab.xml EX-101.LAB 634032
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20200630_pre.xml EX-101.PRE 411855
10 EXTRACTED XBRL INSTANCE DOCUMENT lly-20200630_htm.xml XML 3808049
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 201064667
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences